Chemo Pharma Laboratories Ltd has informed BSE that the Meeting of the Board of Directors of the Company will be held on October 24, 2016, inter alia, to transact the following business:
1. To consider and approve the Un-Audited Financial Results for the quarter ended September 30, 2016.
2. To place and take on record the Limited Review Report on Un-Audited Financial Results for the quarter ended September 30, 2016.